BioCryst Pharmaceuticals, Inc. (BCRX)

NMS – Real Time Price. Currency in USD

9.71

+0.90 (10.28%)

Market open: May 13, 2026, 2:44 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

875M

451M

331M

271M

Cost of goods sold

-20M

-14M

-6M

-8M

Gross Profit

854M

437M

325M

263M

Operating expenses (excl. COGS)

-513M

-440M

-429M

-411M

Operating Income

341M

-3M

-104M

-148M

Non-operating income, total

-74M

-84M

-123M

-96M

Pretax income

267M

-87M

-226M

-244M

Equity in earnings

Taxes

-4M

-2M

-310K

-3M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

264M

-89M

-227M

-247M

BioCryst Pharmaceuticals, Inc. (BCRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioCryst Pharmaceuticals, Inc. (BCRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

BioCryst Pharmaceuticals, Inc. (BCRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioCryst Pharmaceuticals, Inc. (BCRX)

Income Statement (Annual)

Income Statement (Annual)